BackCharles River Laboratories International Overview
Charles River Laboratories International Inc.

Charles River Laboratories International P/E Ratio

Charles River Laboratories International (CRL) has a P/E ratio of -57.49, below the Healthcare sector average of 25.75.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-57.49

P/E Ratio

-57.49

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Charles River Laboratories International (CRL) FAQ

As of the most recent data, CRL shows a P/E ratio of -57.49. That is below the Healthcare sector average of 25.75. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 25.75. Charles River Laboratories International is at -57.49, which is lower that average. That is roughly 323.2% below the sector mean. Use the comparison chart on this page to see how CRL stacks up against individual peers as well.

Investors watch CRL's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Charles River Laboratories International's latest reading is -57.49. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Charles River Laboratories International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -57.49) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 25.75, while CRL is at -57.49. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.